Mesa Laboratories ROE 2010-2025 | MLAB
Current and historical return on equity (ROE) values for Mesa Laboratories (MLAB) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Mesa Laboratories ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.00B | $0.16B | -1.91% |
| 2024-12-31 | $-0.25B | $0.16B | -164.05% |
| 2024-09-30 | $-0.25B | $0.16B | -114.88% |
| 2024-06-30 | $-0.25B | $0.15B | -92.36% |
| 2024-03-31 | $-0.26B | $0.15B | -77.04% |
| 2023-12-31 | $0.00B | $0.40B | 0.25% |
| 2023-09-30 | $0.00B | $0.39B | -0.26% |
| 2023-06-30 | $0.00B | $0.39B | 0.26% |
| 2023-03-31 | $0.00B | $0.39B | 0.26% |
| 2022-12-31 | $0.00B | $0.39B | -0.52% |
| 2022-09-30 | $0.00B | $0.37B | -1.04% |
| 2022-06-30 | $0.00B | $0.38B | -0.25% |
| 2022-03-31 | $0.00B | $0.39B | 0.50% |
| 2021-12-31 | $0.01B | $0.40B | 2.00% |
| 2021-09-30 | $0.01B | $0.40B | 1.24% |
| 2021-06-30 | $0.00B | $0.40B | 0.99% |
| 2021-03-31 | $0.00B | $0.41B | 0.75% |
| 2020-12-31 | $0.00B | $0.41B | -0.57% |
| 2020-09-30 | $0.00B | $0.39B | -0.65% |
| 2020-06-30 | $0.00B | $0.38B | -0.75% |
| 2020-03-31 | $0.00B | $0.22B | 1.00% |
| 2019-12-31 | $0.00B | $0.23B | 2.31% |
| 2019-09-30 | $0.01B | $0.23B | 7.05% |
| 2019-06-30 | $0.01B | $0.12B | 7.19% |
| 2019-03-31 | $0.01B | $0.11B | 6.50% |
| 2018-12-31 | $0.01B | $0.11B | 9.55% |
| 2018-09-30 | $0.00B | $0.11B | -1.98% |
| 2018-06-30 | $0.00B | $0.11B | -0.99% |
| 2018-03-31 | $0.00B | $0.10B | -3.01% |
| 2017-12-31 | $0.00B | $0.09B | -3.02% |
| 2017-09-30 | $0.01B | $0.11B | 11.06% |
| 2017-06-30 | $0.01B | $0.10B | 11.49% |
| 2017-03-31 | $0.01B | $0.10B | 11.89% |
| 2016-12-31 | $0.01B | $0.09B | 12.32% |
| 2016-09-30 | $0.01B | $0.09B | 12.79% |
| 2016-06-30 | $0.01B | $0.09B | 13.21% |
| 2016-03-31 | $0.01B | $0.09B | 14.95% |
| 2015-12-31 | $0.01B | $0.08B | 12.94% |
| 2015-09-30 | $0.01B | $0.08B | 12.00% |
| 2015-06-30 | $0.01B | $0.08B | 13.75% |
| 2015-03-31 | $0.01B | $0.07B | 12.81% |
| 2014-12-31 | $0.01B | $0.07B | 14.71% |
| 2014-09-30 | $0.01B | $0.07B | 15.44% |
| 2014-06-30 | $0.01B | $0.07B | 14.63% |
| 2014-03-31 | $0.01B | $0.06B | 15.38% |
| 2013-12-31 | $0.01B | $0.06B | 16.14% |
| 2013-09-30 | $0.01B | $0.06B | 16.82% |
| 2013-06-30 | $0.01B | $0.05B | 17.56% |
| 2013-03-31 | $0.01B | $0.05B | 18.27% |
| 2012-12-31 | $0.01B | $0.05B | 17.02% |
| 2012-09-30 | $0.01B | $0.05B | 17.78% |
| 2012-06-30 | $0.01B | $0.05B | 18.60% |
| 2012-03-31 | $0.01B | $0.04B | 19.51% |
| 2011-12-31 | $0.01B | $0.04B | 20.51% |
| 2011-09-30 | $0.01B | $0.04B | 18.92% |
| 2011-06-30 | $0.01B | $0.04B | 17.02% |
| 2011-03-31 | $0.01B | $0.04B | 14.81% |
| 2010-12-31 | $0.00B | $0.03B | 12.31% |
| 2010-09-30 | $0.00B | $0.03B | 12.70% |
| 2010-06-30 | $0.00B | $0.03B | 13.11% |
| 2010-03-31 | $0.00B | $0.03B | 13.56% |
| 2009-12-31 | $0.00B | $0.03B | 13.91% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.381B | $0.241B |
| MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $183.063B | 22.15 |
| Intuitive Surgical (ISRG) | United States | $172.911B | 71.67 |
| IDEXX Laboratories (IDXX) | United States | $53.117B | 55.28 |
| Edwards Lifesciences (EW) | United States | $45.606B | 30.23 |
| Alcon (ALC) | Switzerland | $42.656B | 28.83 |
| IQVIA Holdings (IQV) | United States | $32.339B | 18.27 |
| DexCom (DXCM) | United States | $31.357B | 47.03 |
| Mettler-Toledo (MTD) | United States | $27.274B | 32.37 |
| STERIS (STE) | Ireland | $24.334B | 25.90 |
| Waters (WAT) | United States | $17.669B | 24.27 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.740B | 0.00 |
| Hologic (HOLX) | United States | $15.342B | 16.62 |
| Penumbra (PEN) | United States | $10.038B | 73.33 |
| Sysmex ADR (SSMXY) | Japan | $8.699B | 27.64 |
| Globus Medical (GMED) | United States | $8.500B | 19.56 |
| Masimo (MASI) | United States | $8.473B | 28.51 |
| Teleflex (TFX) | United States | $5.432B | 8.77 |
| Glaukos (GKOS) | United States | $5.264B | 0.00 |
| TransMedics (TMDX) | United States | $4.501B | 68.42 |
| Integer Holdings (ITGR) | United States | $3.839B | 19.16 |
| LivaNova (LIVN) | United Kingdom | $2.897B | 16.58 |
| Veracyte (VCYT) | United States | $2.414B | 33.35 |
| Alphatec Holdings (ATEC) | United States | $2.338B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.247B | 0.00 |
| Artivion (AORT) | United States | $2.063B | 104.12 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 24.49 |
| Elekta AB (EKTAY) | Sweden | $1.874B | 16.84 |
| Pulse Biosciences (PLSE) | United States | $1.130B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.100B | 6.30 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| IRadimed (IRMD) | United States | $0.903B | 43.83 |
| Tandem Diabetes Care (TNDM) | United States | $0.752B | 0.00 |
| AxoGen (AXGN) | United States | $0.679B | 0.00 |
| SiBone (SIBN) | United States | $0.677B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.656B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.552B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.527B | 4.23 |
| OrthoPediatrics (KIDS) | United States | $0.504B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.499B | 8.81 |
| Treace Medical Concepts (TMCI) | United States | $0.436B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.58 |
| Pacific Biosciences Of California (PACB) | United States | $0.384B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.368B | 0.00 |
| RxSight (RXST) | United States | $0.340B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.339B | 0.00 |
| NeuroPace (NPCE) | United States | $0.308B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.290B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.289B | 19.92 |
| Neuronetics (STIM) | United States | $0.256B | 0.00 |
| 908 Devices (MASS) | United States | $0.253B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.226B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.202B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.168B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.128B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.106B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.088B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.018B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.14 |